SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
W. B. Alsoussi, S. K. Malladi, J. Q. Zhou…·A. H. Ellebedy
This study shows that SARS-CoV-2 boosting induces GC B cell responses and that Omicron-based vaccines can elicit novel epitope-specific antibodies despite antigenic imprinting.